ADVOCATE | CONNECT | INSPIRE

GEORGIA BIO'S MISSION

is to advance the growth of Georgia’s life sciences industry and foster strategic
partnerships that can create a healthier world

Make Your Voice Be Heard

Georgia Bio is your advocate on the state and federal level to ensure the innovation economy is thriving.

What Interests You?

Ag/Industrial/ Environmental Biotech

Biopharma

Digital Health

Education & Workforce Development

Emerging Companies

Global & Public Health

MedTech & Devices

Students & Young Professionals

Accelerating Life Sciences Across Georgia

Georgia Bio is an independent, non-profit 501(c)(3) trade association whose mission is to advance the growth of Georgia’s life sciences industry and foster strategic partnerships that can create a healthier world. To accomplish this mission, Georgia Bio works on behalf of 200 member organizations to drive public policy, build a network of industry leaders, create access to capital, introduce cutting-edge STEM education programs, and create robust value-driven purchasing programs.

Champion Members

ONE VOICE

Advancing Georgia's Life Sciences IndustrySharing New KnowledgeGrowing the Bottom Line - and the Bioeconomy

Upcoming Events

2021 I-Corps Bio-Entrepreneurship Workshop

Jun 07, 2021—Jun 18, 2021

Bio Digital

Jun 10, 2021—Jun 18, 2021

Virtual

Patient Advocacy Alliance Roundtable

Jun 23, 2021 1:00PM—2:30PM

View Latest News

Mikart acquires state-of-the-art Korsch XM12 to meet client demands for complex formulation development & production of oral solid dose products

June 14, 2021

ATLANTA, June 11, 2021 /PRNewswire/ — Mikart, LLC a comprehensive contract development and manufacturing organization recently acquired a state-of-the-art Korsch XM12 to…

Read More

Novavax: Large study finds COVID-19 shot about 90% effective

June 14, 2021

Vaccine maker Novavax said Monday its COVID-19 shot was highly effective against the disease and also protected against variants in…

Read More

PFIZER AND BIONTECH TO PROVIDE 500 MILLION DOSES OF COVID-19 VACCINE TO U.S. GOVERNMENT FOR DONATION TO POOREST NATIONS

June 11, 2021

U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first half of…

Read More